Clinical solutions

Powering clinical diagnostics with future-proof AI

For pathology labs looking to increase productivity and improve diagnostic accuracy, Aiforia's clinical solutions offer AI-supported image-based diagnostics with intelligent visualization, automated screening, and reporting tools in one cloud-based platform. Pathologists can make the most of a digitized workflow and fully harness their expertise by automating repetitive tasks and increasing the speed and accuracy of case reviews. 

Only certain Aiforia® Clinical AI models and the Aiforia® Clinical Suite Viewer are CE-IVD marked for diagnostic use in EU and EEA countries, see here for the full list: www.aiforia.com/aiforia-clinical-solutions. In all other countries, the use is limited to Research Use Only, not for use in diagnostic procedures.

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer

Breast Cancer Suite

Aiforia® Breast Cancer Grading
Aiforia® Breast Cancer Ki67
Aiforia® Breast Cancer ER
Aiforia® Breast Cancer PR
Aiforia® Breast Cancer HER2
breast-cancer-grading_image 1

The AI model supports the histological grading of breast cancer in whole slide images (WSI) of H&E stained tissue biopsies. It detects invasive carcinoma and ductal carcinoma in situ (DCIS) and scores the grading components mitotic count, tubulus formation, and nuclear pleomorphism. It has been designed based on the Nottingham Grading System. 


Aiforia® Breast Cancer Grading is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Breast Ki67 with AI masks

The AI model supports the detection of invasive carcinoma and scoring of Ki67 positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time in the whole slide image scoring (up to 55% faster)

CE-IVD marked for diagnostic use in EU and EEA countries

Breast ER with AI masks

The AI model supports the detection of invasive carcinoma and scoring of ER positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 47% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Breast PR with AI masks

The AI model supports the detection of invasive carcinoma and scoring of PR positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 16% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

BrCa_HER2_10x_cellmask2-1

The Al model supports the detection of invasive carcinoma and scoring of HER2 positivity and intensity in tumor cells from whole slide images
(WSI) of breast tissue. The Al model has been designed according to CAP recommendations for HER2 analysis.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time (up to 16% faster)


Aiforia® Breast Cancer HER2 is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Breast Cancer Suite

Aiforia® Breast Cancer Grading

breast-cancer-grading_image 1

The AI model supports the histological grading of breast cancer in whole slide images (WSI) of H&E stained tissue biopsies. It detects invasive carcinoma and ductal carcinoma in situ (DCIS) and scores the grading components mitotic count, tubulus formation, and nuclear pleomorphism. It has been designed based on the Nottingham Grading System. 


Aiforia® Breast Cancer Grading is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Aiforia® Breast Cancer Ki67

Breast Ki67 with AI masks

The AI model supports the detection of invasive carcinoma and scoring of Ki67 positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time in the whole slide image scoring (up to 55% faster)

CE-IVD marked for diagnostic use in EU and EEA countries

Aiforia® Breast Cancer ER

Breast ER with AI masks

The AI model supports the detection of invasive carcinoma and scoring of ER positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 47% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Aiforia® Breast Cancer PR

Breast PR with AI masks

The AI model supports the detection of invasive carcinoma and scoring of PR positive and negative tumor cells from whole slide images (WSI) or from selected image areas of cancerous breast tissue.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 16% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Aiforia® Breast Cancer HER2

BrCa_HER2_10x_cellmask2-1

The Al model supports the detection of invasive carcinoma and scoring of HER2 positivity and intensity in tumor cells from whole slide images
(WSI) of breast tissue. The Al model has been designed according to CAP recommendations for HER2 analysis.

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time (up to 16% faster)


Aiforia® Breast Cancer HER2 is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Lung Cancer Suite

Aiforia® Lung Cancer PD-L1
Lung PD-L1 with AI masks

The AI model supports the detection of invasive carcinoma areas in patient samples and the scoring of PD-L1 negative and positive tumor cells in non-small cell lung (NSCLC) cancer cases. 

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time (up to 46% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Lung Cancer Suite

Aiforia® Lung Cancer PD-L1

Lung PD-L1 with AI masks

The AI model supports the detection of invasive carcinoma areas in patient samples and the scoring of PD-L1 negative and positive tumor cells in non-small cell lung (NSCLC) cancer cases. 

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Improved diagnostic concordance by increasing pathologist agreement
  • Saved time (up to 46% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Prostate Cancer Suite

Aiforia® Prostate Cancer Gleason Grade Groups
Aiforia® Prostate Cancer PNI
Aiforia® Prostate Cancer G4 cribriform
Aiforia® Prostate Cancer HG-PIN
Prostate_20x_AImasks_cropped

The AI model supports the detection of adenocarcinoma and assists Gleason grade grouping from whole slide images (WSI).

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 36% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

PNI 40x all masks-1

The AI model supports the detection of perineural invasion (PNI) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer PNI is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

G4 crib 20x adv mask only-1

The AI model supports the detection of Gleason 4 cribriform pattern in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer G4 cribriform is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

HGPIN 40x adv mask only-1

The AI model supports the detection of high-grade prostatic intraepithelial neoplasia (high-grade PIN) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer HG-PIN is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Prostate Cancer Suite

Aiforia® Prostate Cancer Gleason Grade Groups

Prostate_20x_AImasks_cropped

The AI model supports the detection of adenocarcinoma and assists Gleason grade grouping from whole slide images (WSI).

Clinical Validation
  • Showed excellent correlation with visual diagnosis
  • Saved time (up to 36% faster)


CE-IVD marked for diagnostic use in EU and EEA countries

Aiforia® Prostate Cancer PNI

PNI 40x all masks-1

The AI model supports the detection of perineural invasion (PNI) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer PNI is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Aiforia® Prostate Cancer G4 cribriform

G4 crib 20x adv mask only-1

The AI model supports the detection of Gleason 4 cribriform pattern in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer G4 cribriform is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Aiforia® Prostate Cancer HG-PIN

HGPIN 40x adv mask only-1

The AI model supports the detection of high-grade prostatic intraepithelial neoplasia (high-grade PIN) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer HG-PIN is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Colon Suite

Aiforia® Colorectal Cancer QuantCRC
QuantCRC_image

The prognostic AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for treatment decisions. The AI model was developed and validated in collaboration with the Mayo Clinic.

Clinical Validation
  • Verified and validated in the Aiforia® Platform using whole slide images from eight independent hospitals and patient cohorts
  • Improved risk stratification as compared to the American Society of Clinical Oncology staging


Aiforia® Colorectal Cancer QuantCRC is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas.

Learn more

Colon Suite

Aiforia® Colorectal Cancer QuantCRC

QuantCRC_image

The prognostic AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for treatment decisions. The AI model was developed and validated in collaboration with the Mayo Clinic.

Clinical Validation
  • Verified and validated in the Aiforia® Platform using whole slide images from eight independent hospitals and patient cohorts
  • Improved risk stratification as compared to the American Society of Clinical Oncology staging


Aiforia® Colorectal Cancer QuantCRC is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas.

Learn more

Using Prognostic AI Models in Pathology:
Case Colorectal Cancer

Join our upcoming webinar on June 13, 2024 

Why use AI?

Increased efficiency
Increased efficiency

Diagnose more patients in less time by unbinding yourself from time-consuming, manual tasks.

 

Advanced precision
Advanced precision

Improve diagnostic accuracy and be confident in your decision-making.

 

Improved consistency
Improved consistency

Reduce variability to standardize your sample review and ensure democratized patient care.

 

Aiforia® Clinical Suites: Al-powered digital pathology workflow

What makes Aiforia unique?

ic_our_ai-1_pink

Future-proof

Together with our customers, we continue to develop new groundbreaking AI models, with thousands of models already developed for research use. We’re committed to providing cutting-edge deep learning AI models designed to meet the evolving needs of our customers. As clinical diagnostics become increasingly complex, our advanced software will ensure you stay at the forefront of technology.

ic_discover_pink

Transparency

Aiforia makes a commitment to keeping our AI algorithms transparent and understandable. You remain in control, see how analyses are conducted, and participate in the training process. AI models serve as first-read support while the expert verifies the results. We offer our customers with fully quantifiable data and results that can easily be adjusted.

ic_wellbeing_pink

Ease of use

The Aiforia software requires no data scientists or coding expertise. Our team of experts integrates the solutions into existing IT infrastructures. We acknowledge that every lab is different, so we optimize each model for each lab’s individual needs and monitor their performance to deliver continuous improvement. Aiforia’s software allows customers to confidently scale up their operations while paying only for what they need.

ic_secure_pink

Security

We take data privacy and security very seriously.  We hold several globally relevant quality and security certifications, so our customers can be sure their sample and patient data is safe.* Customers determine what information is stored in the cloud and can opt for a private version.
 

*Our image analysis solutions are developed and maintained securely per ISO 27001:2022 and SOC 2 Type II security standards, and  ISO 13485:2016 quality standards. 

Statement on Security

Aiforia Technologies holds information security to the highest standard. We hold several globally relevant quality and security certifications, so you can be sure your sensitive information is safe.

 

ON-DEMAND WEBINAR

Aiforia’s CE-IVD marked clinical AI models for Ki67 and PD-L1

Watch this recording for an intro and demo from pathologists Dr. Laury and Dr. Sjöblom on the Aiforia® Clinical AI Model for Lung Cancer; PD-L1 and Aiforia® Clinical AI Model for Breast Cancer; Ki67. 

 

Aiforia’s CE-IVD marked clinical AI models for Ki67

 

Why the cloud?

A cloud-based platform allows any laboratory with infinitely scalable digital pathology deployment.

Our services

Integration Services

Integration can be straightforward. Aiforia solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.

Cloud Hosting Services

Choose to host on our secure shared or private cloud environment. You can also opt to host on your own cloud provider (preferred partners include MS Azure and GCP).

Custom AI Services

AI models developed by scientists, for scientists. With Custom AI Services, Aiforia's scientists build AI models for your specific needs.

Case studies, resources and more

AI for clinical diagnostics

prostate_grading_after

INTERVIEW

Benefits of AI and digital pathology to the clinical lab

We interviewed two pathologists from different hospitals, Dr. Kevin Sandeman and Dr. Tuomas Mirtti, on their thoughts about the impact and benefits of AI and digital pathology in clinical diagnostics.

Read the case >

Generic bg - AI duplicate-1

BLOG POST

5 reasons to use AI in clinical diagnostics

What additional benefit does AI bring to the digitized pathology workflow in clinical diagnostics? Read our article to find out.

Read the case >

Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

NEWS

Aiforia obtains CE-IVD mark for AI-supported breast cancer diagnostics

Read our article to find out why the Aiforia Ki67 AI Model is a first-of-its kind diagnostic tool for pathologists to harness the full potential of their own expertise.

Read the case >

Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

NEWS

Epredia and Aiforia announce partnership 

We are thrilled to announce our partnership with Epredia, a global leader in precision cancer diagnostics, for the global distribution of our AI-powered pathology software!

Read the case >

Generic bg - news duplicate 2-1

NEWS

Aiforia and X-ZELL partner to scale up novel AI-powered method for early cancer detection

Aiforia partners with med-tech company X-ZELL to combine deep learning software with rare cell detection tech to build a novel, AI-powered method for early cancer detection.

Read the case >

Book a demo

Seeing is believing

Get a virtual demo from one of our experts

During the personalized walkthrough of Aiforia's software and solutions find out how to enhance your image analysis work in:

  • Diagnostic pathology
  • Preclinical studies
  • Medical research
  • Remote education